MPM BioImpact’s Liquidia Corp LQDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$111M Sell
1,386,174
-18,984
-1% -$1.02M 6.74% 3
2026
Q1
$53M Buy
1,405,158
+4,289
+0.3% +$159K 4.1% 4
2025
Q4
$48.3M Buy
1,400,869
+1,200,869
+600% +$34.2M 5.53% 3
2025
Q3
$4.55M Buy
+200,000
New +$4.34M 0.74% 32

Other funds holding LQDA

MPM BioImpact's LQDA Position: Q2 2026 in Review

MPM BioImpact reduced its Liquidia Corp (LQDA) stake by 1.4% in Q2 2026, selling an estimated $1.02M and leaving 1,386,174 shares worth $111M. The position accounts for 6.74% of the portfolio, ranked #3.

MPM BioImpact first reported a position in LQDA in Q3 2025 and has held it in 4 quarters since. 336 funds tracked by Wall St. Rank hold LQDA as of Q2 2026.

  • MPM BioImpact held 1,386,174 shares of Liquidia Corp worth $111M as of Q2 2026.
  • MPM BioImpact sold 18,984 Liquidia Corp shares in Q2 2026, an estimated $1.02M.
  • Liquidia Corp made up 6.74% of MPM BioImpact's portfolio in Q2 2026, its #3 holding.
  • MPM BioImpact first reported a position in Liquidia Corp in Q3 2025 and has held it in 4 quarters since.
  • 336 funds tracked by Wall St. Rank held Liquidia Corp as of Q2 2026.

Based on MPM BioImpact's 13F filing for Q2 2026, filed 14 Aug 2026.